Compare CNTA & AX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTA | AX |
|---|---|---|
| Founded | 2020 | 1999 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.6B |
| IPO Year | 2021 | 2004 |
| Metric | CNTA | AX |
|---|---|---|
| Price | $39.50 | $98.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $43.17 | ★ $103.14 |
| AVG Volume (30 Days) | ★ 4.9M | 310.1K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ 4.17 |
| Revenue | $15,000,000.00 | ★ $65,789,000.00 |
| Revenue This Year | N/A | $24.76 |
| Revenue Next Year | N/A | $10.86 |
| P/E Ratio | ★ N/A | $23.65 |
| Revenue Growth | N/A | ★ 1.78 |
| 52 Week Low | $10.95 | $61.96 |
| 52 Week High | $40.26 | $101.92 |
| Indicator | CNTA | AX |
|---|---|---|
| Relative Strength Index (RSI) | 73.71 | 65.78 |
| Support Level | $39.16 | $81.88 |
| Resistance Level | $40.26 | $100.44 |
| Average True Range (ATR) | 0.22 | 2.57 |
| MACD | -0.45 | 0.45 |
| Stochastic Oscillator | 52.34 | 90.48 |
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.